Literature DB >> 10197268

Graves' disease following successful treatment of severe aplastic anaemia with antilymphocyte globulin.

A Todd1, J Todd.   

Abstract

This case report is only the third report of thyroid dysfunction following the administration of anti-lymphocyte globulin for severe aplastic anaemia. It is the first report of the development of Grave's disease. We discuss a possible mechanism by which this may occur and highlight instances of other immune-mediated diseases occurring in ALG treated patients.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10197268     DOI： 10.1046/j.1365-2257.1999.00190.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN： 0141-9854


  7 in total

1.  Guillain Barré syndrome precipitated by the use of antilymphocyte globulin in the treatment of severe aplastic anaemia.

Authors:  B Kaya; C E Davies; H E Oakervee; N C Silver; J Gawler; J D Cavenagh
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

Review 2.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

3.  Development of Graves' disease in a patient under immunosuppressive therapy after liver transplantation.

Authors:  T Bednarczuk; U Makowska; J Nauman
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

4.  Autoimmune thyroid disease following hematopoietic stem cell transplantation in childhood cancer survivors.

Authors:  Shunsuke Shimazaki; Itsuro Kazukawa; Masanori Minagawa
Journal:  Clin Pediatr Endocrinol       Date:  2021-12-16

5.  Evolution of Graves' Disease during Immune Reconstitution following Nonmyeloablative Haploidentical Peripheral Blood Stem Cell Transplantation in a Boy Carrying Germline SAMD9L and FLT3 Variants.

Authors:  Peng Peng Ip; Li-Hua Fang; Yi-Ling Shen; Kuan-Chiun Tung; Ming-Tsong Lai; Li-Ying Juan; Liuh-Yow Chen; Rong-Long Chen
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208

6.  Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies.

Authors:  Pieter Gillard; Volkert Huurman; Bart Van der Auwera; Brigitte Decallonne; Kris Poppe; Bart O Roep; Frans Gorus; Chantal Mathieu; Daniel Pipeleers; Bart Keymeulen
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 17.152

7.  Graves disease following rabbit antithymocyte globulin treatment of severe aplastic anemia in a Korean child.

Authors:  In Su Choi; Han Kyul Kim; Dong Kyun Han; Hee Jo Baek; Hae In Jang; Chan Jong Kim; Hoon Kook
Journal:  Korean J Pediatr       Date:  2015-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.